ClinicalTrials.Veeva

Menu

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy

E

Eye & ENT Hospital of Fudan University

Status

Enrolling

Conditions

Chronic Dacryocystitis

Treatments

Device: Photosensitive hydrogel
Device: 6-0 absorbable stitches

Study type

Interventional

Funder types

Other

Identifiers

NCT06551766
2023017

Details and patient eligibility

About

To study the effect of Photosensitive hydrogel used for suture free anastomosis of lacrimal cyst and nasal mucoperiosteal flap in endoscopic nasal dacryocystostomy, and evaluate its adhesion to lacrimal cyst and nasal mucoperiosteal flap, promoting wound healing, forming a good anastomosis, preventing postoperative anastomosis and shortening operation time. Twenty patients with chronic dacryocystitis were randomly divided into photosensitive hydrogel group and suture group.Symptoms and nasal endoscopy were followed up 2, 6, and 12 weeks after surgery for both groups. And also adverse events were recorded at each follow-up.

Full description

After endoscopic dacryocystonasal anastomosis, granulation and/or cicatricial adhesion are the main reasons for surgical failure. How to achieve the ideal fit between the lacrimal sac flap and the nasal mucoperiosteal flap and avoid the proliferation of granulation and cicatricial adhesion is very important for the success of the operation. In this study, "photocoupling reaction" technology was used to achieve seamless integration and strong adhesion of photosensitive hydrogel materials to the wound, and the photohydrogel was applied to suture free adhesion and wound repair of the lacrimal cyst mucosal flap and nasal mucosal flap in endoscopic nasal Dacryocystostomy (En-DCR), and its feasibility, safety and effectiveness were evaluated.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Voluntarily participate in this clinical study and sign the informed consent;
  2. Gender is not limited, age 18-75 years old;
  3. The patient had symptoms and signs of chronic dacryocystitis, and the results of lacrimal passage irrigation suggested that the lower rush and return or upper rush and lower return, accompanied by mucous or purulent discharge reflux;
  4. Lacrimal duct angiography suggests nasolacrimal duct obstruction without lacrimal canaliculi and/or duct obstruction.

Exclusion criteria

  1. Age < 18 or > 75 years old;
  2. Previous history of dacryocystonasal anastomosis;
  3. Abnormal coagulation function;
  4. Tumors of lacrimal passage, especially in patients with papilloma or malignant tumors;
  5. in the acute dacryocystitis attack stage;
  6. obvious scar constitution;
  7. Complicated with serious nasal diseases, such as severe allergic rhinitis, chronic rhinosinusitis and nasal polyps, acute suppurative rhinosinusitis, severe atrophic rhinitis, and severe deviation of nasal septum;
  8. Have serious heart, liver, kidney, lung and other basic diseases, can not tolerate general anesthesia;
  9. Distance from the hospital, postoperative review is not convenient;
  10. Participated in other clinical trials within the last 3 months;
  11. Any medical history that the investigator determines may interfere with the test results or increase the patient's risk.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Photosensitive hydrogel
Experimental group
Description:
The photosensitive hydrogel is composed of tetra-armed poly(ethylene glycol) (4aPEGNB)and methacrylate-modified hyaluronic acid (HAMA).The hydrogel can be rapidly photocured under light induction at 395nm.
Treatment:
Device: Photosensitive hydrogel
Suture fixation
Active Comparator group
Description:
The suture is fixed with 6-0 absorbable thread.
Treatment:
Device: 6-0 absorbable stitches

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems